Vitamin D के लिए महिला पैटर्न बाल झड़ना
A18 अध्ययनों (2 meta-analyses) पर आधारित, में कुल 15,494 प्रतिभागियों के साथ। अध्ययनों के बीच परिणाम मिश्रित हैं।
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
निष्कर्ष
Research shows that women with pattern hair loss often have lower vitamin D levels, but supplementing with vitamin D alone is unlikely to significantly improve this condition — it may be one supportive factor among many.
- Lower vitamin D levels are consistently found in women with pattern hair loss
- Supplementation alone is less effective than established options like minoxidil
- Vitamin D receptor gene variants may influence susceptibility
- Maintaining adequate vitamin D may support overall hair health but is not a standalone solution
Key Study Findings
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None
बनाम: Placebo
प्रभाव: None
None
Meta-analysis
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.
Dose: None
बनाम: Placebo
प्रभाव: OR=2.84 (AA vs controls), OR=5.24 (FPHL vs controls)
p<0.01
cross-sectional observational
n=120
Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis.
Dose: None
बनाम: Placebo
प्रभाव: 79.17% of patients with diffuse hair fall were vitamin D3 deficient (mean 17.33 ± 5.43 ng/mL)
None
meta_analysis
n=10670
Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis.
Dose: not applicable (observational meta-analysis)
बनाम: Placebo
प्रभाव: WMD -7.29 ng/mL (95% CI -9.21, -5.38); OR for vitamin D deficiency 3.11 (95% CI 2.29, 4.22)
not explicitly stated; CI does
Case-control
n=165
The development of non-scarring alopecia in women who wear the hijab.
Dose: None
बनाम: Placebo
प्रभाव: OR=4.1 (95% CI 1.2-14.1) for vitamin D deficiency and telogen effluvium
p=0.02
Other
Serum ferritin and vitamin D levels in women with non-scarring alopecia.
Dose: None
बनाम: None
Outcome: None
प्रभाव: None
None
जनसंख्या: Women with non-scarring alopecia
Key Statistics
19
अध्ययन
15494
प्रतिभागी
↔
Mixed
A
ग्रेड
Referenced Papers
Journal of drugs …
2025
Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis.
Meta-Analysis
Journal of cosmetic …
2024
7 उद्धरण
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.
Systematic Review
Frontiers in nutrition
2024
4 उद्धरण
Dermatology practical & …
2024
Archives of dermatological …
2023
3 उद्धरण
Journal of cosmetic …
2022
10 उद्धरण
Journal of cosmetic …
2022
4 उद्धरण
Journal of cosmetic …
2021
44 उद्धरण
International journal of …
2020
18 उद्धरण
Journal of cosmetic …
2020
17 उद्धरण
The mental health …
2020
7 उद्धरण
Indian journal of …
2020
5 उद्धरण
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
Meta-Analysis
The Journal of …
2019
101 उद्धरण
NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India.
Observational
Journal of cosmetic …
2019
25 उद्धरण
Experimental dermatology
2017
82 उद्धरण
International journal of …
2017
61 उद्धरण
International journal of …
2016
42 उद्धरण
International journal of …
2016
28 उद्धरण
Skin pharmacology and …
2013
127 उद्धरण
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
सामान्य रूप से उपयोग की जाने वाली खुराकें
- general:
- 600-800 IU/day
- deficiency:
- 1,000-5,000 IU/day
अधिकतम सीमा: 4,000 IU/day
अनुसंधान में अध्ययन की गई खुराकें
| खुराक | अवधि | प्रभाव | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Negative | -- |
| None | -- | Neutral | 120 |
| not applicable (observational meta-analysis) | -- | Negative | 10670 |
| None | -- | Positive | 165 |
| None | -- | Mixed | -- |
| None | -- | Negative | -- |
| 1000 IU vitamin D3 daily | 16 weeks | Positive | 2 |
सेवन का सर्वोत्तम समय: With a fat-containing meal for optimal absorption
Safety & Side Effects
रिपोर्ट किए गए दुष्प्रभाव
- ⚠ Hypercalcemia at very high doses (nausea, vomiting, weakness)
- ⚠ Kidney stones with excessive long-term use
- ⚠ Constipation
- ⚠ Metallic taste
ज्ञात अंतःक्रियाएँ
- ● Thiazide diuretics (may increase risk of hypercalcemia)
- ● Corticosteroids (reduce vitamin D absorption and metabolism)
- ● Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
सहनीय अधिकतम सेवन: 4,000 IU/day
कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
Frequently Asked Questions
Does Vitamin D help with महिला पैटर्न बाल झड़ना?
Based on 19 studies with 15,494 participants, there is strong evidence from multiple clinical trials that Vitamin D may support महिला पैटर्न बाल झड़ना management. Our evidence grade is A (Strong Evidence).
How much Vitamin D should I take for महिला पैटर्न बाल झड़ना?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and महिला पैटर्न बाल झड़ना?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 15,494 total participants. The overall direction of effect is mixed.
Related Evidence
इसके लिए अन्य सामग्री महिला पैटर्न बाल झड़ना
Vitamin D अन्य स्वास्थ्य स्थितियों के लिए
FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।